🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Polaryx Therapeutics, Inc. (PLYX)
NASDAQ: PLYX · Real-Time Price · USD
1.510
-0.100 (-6.21%)
Nov 19, 2026, 4:00 PM EST - Market closed

Polaryx Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
---0.10
Net Debt / Equity Ratio
-1.11-1.13-0.980.10
Quick Ratio
8.458.5015.990.00
Current Ratio
8.628.5517.302.23
Return on Equity (ROE)
-135.49%-193.70%-1013.73%-
Return on Assets (ROA)
-64.90%-96.12%-74.36%-
Return on Capital Employed (ROCE)
-99.60%-171.30%-92.40%-296.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23
Buyback Yield / Dilution
-10.44%-32.81%-219.94%-
SEC Filings: 10-K · 10-Q